Skip to main content
UniHealth

Doctor search

Alice A Chung, MD

Internal Medicine · Stanford

NPI 1376986810

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chung’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A133657 · Current

Licensed to practise in California · since 2014 · expires 2026-12-31 · Boston University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$26,666

Medicare paid this office $26,666 for 258 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)97$6,752$53
Return visit (30+ min)57$5,460$62
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit80$5,070$63
Short return visit (20+ min)49$2,742$55
Return visit (30+ min)18$1,254$66

Procedures Medicare counted

Procedure volume Medicare published
Removal or shaving of skin growth1-10None

Who their Medicare patients are

258 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 13% · Women 58% · Also on Medicaid 16% · Health risk score 1.00. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.

Conditions among them: High blood pressure 54% · Diabetes 20% · Coronary heart disease 20% · Atrial fibrillation 14% · Depression 14% · Chronic kidney disease 13% · Heart failure 12% · Cancer 11% · COPD 7% · Dementia 5%.

The office billed $174,273, Medicare allowed $37,918 and paid $26,666; for 428 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024258428741.00$174,273$26,666
2023241414741.08$151,071$23,640
2022251408741.07$130,133$25,510
2021239370751.09$117,233$24,680
2020166276721.17$77,204$14,790
2019178237731.02$53,656$15,999
2018140177731.23$31,558$9,635
2017212279741.35$33,657$11,351
20164956711.53$9,424$3,501

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Short return visit (20+ min)90$5,982$52
Return visit (30+ min)63$5,130$55
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit72$4,583$64
Short return visit (20+ min)43$2,312$54
Return visit (30+ min)20$1,597$80
Telephone medical discussion with physician, 21-30 minutes11$892$74
Telephone medical discussion with physician, 11-20 minutes17$874$51
Long return visit (40+ min)13$731$56

2022: 8 services

Original Medicare services billed in 2022
Short return visit (20+ min)64$5,172$52
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit65$4,812$74
Short return visit (20+ min)59$3,338$57
Return visit (30+ min)33$3,327$60
Return visit (30+ min)33$2,109$64
Telephone medical discussion with physician, 21-30 minutes16$1,064$59
Telephone medical discussion with physician, 11-20 minutes15$994$55
New patient visit (30+ min)11$819$74

2021: 8 services

Original Medicare services billed in 2021
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit49$4,118$84
Short return visit (20+ min)60$3,826$51
Return visit (30+ min)41$3,281$68
Return visit (30+ min)35$3,067$85
Short return visit (20+ min)59$3,012$49
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit15$2,539$169
Telephone medical discussion with physician, 11-20 minutes18$1,090$54
New patient visit (30+ min)11$638$58

2020: 4 services

Original Medicare services billed in 2020
Short return visit (20+ min)63$4,371$42
Short return visit (20+ min)53$2,291$43
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit13$1,822$140
Telephone medical discussion with physician, 11-20 minutes18$958$40

2019: 4 services

Original Medicare services billed in 2019
Short return visit (20+ min)79$4,580$44
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit31$4,311$139
Return visit (30+ min)25$2,088$70
Short return visit (20+ min)43$1,827$42

2018: 2 services

Original Medicare services billed in 2018
Short return visit (20+ min)105$4,830$37
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit18$2,490$138

2017: 4 services

Original Medicare services billed in 2017
Short return visit (20+ min)165$7,991$39
Return visit (30+ min)27$1,010$37
New patient visit (30+ min)14$676$48
Short return visit15$339$23

2016: 2 services

Original Medicare services billed in 2016
Short return visit (20+ min)29$1,437$50
Return visit (30+ min)15$1,136$67

Drugs they prescribed that Part D paid

$87,343

Pharmacies billed $87,343 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (32 of 1,064) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.

957 generic and fewer than 11 brand-name prescriptions · $87,343 in drug cost · 36 antibiotic prescriptions to 28 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Paxlovid15$1,377$92
Rosuvastatin34$885$26
Atorvastatin118$701$6
Olmesartan Medoxomil42$697$17
Losartan35$694$20
See all 22 drugs
Every Part D drug this clinician prescribed
Paxlovid15$1,377$92
Rosuvastatin34$885$26
Atorvastatin118$701$6
Olmesartan Medoxomil42$697$17
Losartan35$694$20
Levothyroxine36$655$18
Gabapentin23$447$19
Zolpidem29$401$14
Metoprolol24$299$12
Tamsulosin18$298$17
Fluticasone Propionate29$283$10
Pantoprazole11$282$26
Duloxetine16$281$18
Finasteride15$232$15
Metformin20$204$10
Hydrochlorothiazide20$157$8
Allopurinol13$157$12
Famotidine11$144$13
Metformin Hcl Er13$107$8
Lisinopril31$58$2
Amlodipine Besylate53$55$1
Carvedilol11$6$1

Year by year

Part D prescribing by year
20241,0641953% (32)None$87,343
20231,1362113% (32)None$98,213
20221,1651952% (26)None$105,084
20218331424% (29)None$66,719
20207101315% (32)None$60,178
20194591024% (20)16%$36,453
20187171054% (29)14%$71,101
20177101097% (50)None$58,125
20161073821% (22)16%$5,916
201514NoneNoneNone$437

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 20 drugs

Part D drugs prescribed in 2023
Xarelto12$15,653$1,304
Atorvastatin154$1,846$12
Olmesartan Medoxomil29$1,027$35
Duloxetine25$948$38
Levothyroxine46$946$21
Amlodipine Besylate66$730$11
Rosuvastatin18$660$37
Gabapentin38$593$16
Tamsulosin16$578$36
Metformin23$446$19
Losartan54$440$8
Fluticasone Propionate32$436$14
Metoprolol28$377$13
Lisinopril36$343$10
Famotidine12$290$24
Escitalopram14$235$17
Zolpidem27$203$8
Finasteride13$133$10
Oxycodone13$80$6
Hydrochlorothiazide18$75$4

2022: 24 drugs

Part D drugs prescribed in 2022
Myrbetriq11$14,732$1,339
Linzess12$6,303$525
Gabapentin35$1,677$48
Atorvastatin117$1,254$11
Duloxetine18$1,178$65
Levothyroxine48$944$20
Amlodipine Besylate86$703$8
Metoprolol36$513$14
Tamsulosin18$490$27
Losartan54$423$8
Valacyclovir12$388$32
Chlorthalidone19$349$18
Fluticasone Propionate26$292$11
Famotidine13$268$21
Lisinopril45$267$6
Temazepam14$256$18
Methadone11$201$18
Omeprazole15$193$13
Metformin23$187$8
Cyclobenzaprine12$162$13
Hydrochlorothiazide22$153$7
Pantoprazole14$152$11
Zolpidem19$91$5
Triamcinolone Acetonide14$55$4

2021: 19 drugs

Part D drugs prescribed in 2021
Linzess11$5,417$492
Gabapentin16$1,513$95
Atorvastatin56$729$13
Levothyroxine24$635$26
Duloxetine11$538$49
Amlodipine Besylate48$439$9
Escitalopram32$401$13
Metoprolol28$388$14
Losartan35$368$11
Terazosin20$359$18
Fluticasone Propionate16$283$18
Omeprazole30$270$9
Pantoprazole22$255$12
Simvastatin15$184$12
Hydrochlorothiazide22$154$7
Methadone11$144$13
Metformin28$125$4
Lisinopril33$93$3
Zolpidem11$55$5

2020: 16 drugs

Part D drugs prescribed in 2020
Linzess12$5,468$456
Gabapentin15$885$59
Terazosin12$615$51
Levothyroxine19$486$26
Losartan37$485$13
Atorvastatin34$392$12
Amlodipine Besylate48$326$7
Hydrocodone-Acetaminophen13$286$22
Simvastatin21$226$11
Escitalopram21$207$10
Alendronate13$194$15
Lisinopril25$187$7
Hydrochlorothiazide18$106$6
Triamcinolone Acetonide12$81$7
Zolpidem16$73$5
Metoclopramide11$55$5

2019: 8 drugs

Part D drugs prescribed in 2019
Escitalopram20$379$19
Levothyroxine12$364$30
Gabapentin12$257$21
Losartan23$224$10
Amlodipine Besylate36$214$6
Atorvastatin19$155$8
Simvastatin11$122$11
Triamcinolone Acetonide13$54$4

2018: 19 drugs

Part D drugs prescribed in 2018
Lyrica14$9,346$668
Gabapentin25$869$35
Metoprolol15$675$45
Atorvastatin32$554$17
Levothyroxine16$394$25
Omeprazole22$381$17
Methadone14$368$26
Duloxetine14$361$26
Losartan38$301$8
Tamsulosin13$264$20
Amlodipine Besylate52$256$5
Simvastatin14$231$17
Lisinopril24$199$8
Hydrocodone-Acetaminophen13$124$10
Furosemide11$108$10
Sumatriptan11$97$9
Hydrochlorothiazide24$96$4
Spironolactone12$28$2
Trazodone11$28$3

2017: 16 drugs

Part D drugs prescribed in 2017
Lyrica15$9,161$611
Gabapentin32$1,118$35
Levothyroxine23$826$36
Methadone21$633$30
Atorvastatin26$592$23
Enalapril Maleate13$506$39
Amlodipine Besylate38$289$8
Losartan28$209$7
Hydrocodone-Acetaminophen25$207$8
Warfarin11$155$14
Omeprazole19$99$5
Mirtazapine12$97$8
Lisinopril14$88$6
Clonazepam19$74$4
Trazodone14$51$4
Metformin13$49$4

2016: 1 drug

Part D drugs prescribed in 2016
Hydrocodone-Acetaminophen12$219$18

Money from drug and device companies

$130 in 2025

Industry payments by year
202512None$130
202427None$407

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
BiotronikBiomonitor$130
2 payments
  • Meals for Biomonitor · 2025-11-13 · $112
  • Meals · 2025-05-13 · $19
See all 2 published payments
Every published payment
BiotronikMeals · 2025-11-13Biomonitor$112
BiotronikMeals · 2025-05-13None$19
See earlier years (2024)

2024: $407

Payments by company in 2024
Intuitive SurgicalDa Vinci Surgical System$240
2 payments
  • Travel for Da Vinci Surgical System · 2024-08-14 · $221
  • Travel for Da Vinci Surgical System · 2024-08-14 · $19
BiotronikActicor 7 Vr-T Dx$167
5 payments
  • Meals for Acticor 7 Vr-T Dx · 2024-11-21 · $100
  • Meals · 2024-11-11 · $6
  • Meals · 2024-11-08 · $16
  • Meals for Acticor 7 Vr-T Dx · 2024-11-06 · $19
  • Meals for Amvia Edge · 2024-07-22 · $26

Professional record

NPI
1376986810
Licence
CA A133657California A133657: Current · expires 2026-12-31
Trained
Boston University School of Medicine, 2013
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Family medicine (207Q00000X)
Mailing address
300 Pasteur Dr, Palo Alto, CA, 94304
NPI first listed
2013-04-15
NPI last updated
2024-04-28
NPI record certified
2024-04-28

This is when the NPI record was last certified, not a medical board exam.